Cassava Sciences, Inc. (SAVA) Financials
Stock symbol SAVA is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker SAVA was renamed to
FLNA
effective 2026-03-11.
SAVA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 151.7 million | 14.2 million |
| Sept. 30, 2023 | 172.5 million | 17.4 million |
| June 30, 2023 | 197.2 million | 17.9 million |
| March 31, 2023 | 218.1 million | 14.1 million |
SAVA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -22.4 million | 2.1 million |
| Sept. 30, 2023 | -26.6 million | 949000 |
| June 30, 2023 | -19.9 million | 835000 |
| March 31, 2023 | -13.6 million | 673000 |
SAVA Net Income
No data available :(
SAVA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 121.1 million | - | - |
| Sept. 30, 2023 | 142.4 million | - | - |
| June 30, 2023 | 168.4 million | - | - |
| March 31, 2023 | 187.5 million | - | - |
SAVA Shares Outstanding
SAVA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 41000 | 18.7 million | 4.1 million | 356000 |
| Sept. 30, 2023 | 22000 | 23.6 million | 4.3 million | - |
| June 30, 2023 | 6000 | 25.0 million | 3.8 million | - |
| March 31, 2023 | 357000 | 22.1 million | 4.4 million | - |
SAVA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 2.3 million | 356000 |
| Sept. 30, 2023 | - | 392000 |
| June 30, 2023 | - | 391000 |
| March 31, 2023 | - | 391000 |
SAVA
Price: $2.38
52 week price:
Earnings Per Share: -2.22 USD
P/E Ratio: -0.91
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.0 million
Market Capitalization: 98.1 million